Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Other Non-Current Liabilities (2023 - 2026)

BioAge Labs' Other Non-Current Liabilities history spans 3 years, with the latest figure at $370000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 137.18% to $370000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $370000.0, a 137.18% increase, with the full-year FY2025 number at $370000.0, up 137.18% from a year prior.
  • Other Non-Current Liabilities hit $370000.0 in Q4 2025 for BioAge Labs, up from $150000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for BIOA hit a ceiling of $613000.0 in Q3 2024 and a floor of $97000.0 in Q1 2025.
  • Historically, Other Non-Current Liabilities has averaged $246142.9 across 3 years, with a median of $156000.0 in 2024.
  • The widest YoY moves for Other Non-Current Liabilities: up 137.18% in 2025, down 75.53% in 2025.
  • Tracing BIOA's Other Non-Current Liabilities over 3 years: stood at $229000.0 in 2023, then tumbled by 31.88% to $156000.0 in 2024, then skyrocketed by 137.18% to $370000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for BIOA at $370000.0 in Q4 2025, $150000.0 in Q3 2025, and $108000.0 in Q2 2025.